You are here: / / / / A lower maternal cortisol to cortisone ratio precedes clinical diagnosis...

A lower maternal cortisol to cortisone ratio precedes clinical diagnosis of preterm and term preeclampsia by many weeks

Publication: The Journal of Clinical Endocrinology & Metabolism

Jayasuriya NA, Hughes AE, Sovio U, Cook E, Charnock-Jones DS, Smith GCS. J Clin Endocrinol Metab.

15 February 2019

View publication

The NIHR Cambridge BRC is part of the NIHR and hosted by Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge. We are at the heart of the Cambridge Biomedical Campus, Europe’s largest health research area.

Bluesky

Contact Us

Cambridge Biomedical Research Centre
Box 277
Hills Road
Cambridge
CB2 0QQ

Tel: 01223 348490

Useful Links

About Us
Research
Governance Structure
Partners
Publications
PPIE in Research
News/Events
Vacancies
Accessibility
Privacy

cambridgebrc NIHR Cambridge Biomedical Research Centre @cambridgebrc ·
12 Feb

Involved in research? Whatever your role/discipline, please spend 15-20 mins filling out a survey https://bit.ly/41aZ69J from @EthicsSciPublicKavli at @Cambridge_Uni on science engagement with the public? @CamUniEngage @engageWCS @StellenboschUni @CUH_NHS

Reply on Twitter 1889650882251284935 Retweet on Twitter 1889650882251284935 Like on Twitter 1889650882251284935 Twitter 1889650882251284935
cambridgebrc NIHR Cambridge Biomedical Research Centre @cambridgebrc ·
11 Feb

Happy #InternationalDayofWomenandGirlsinScience
To commemorate this annual celebration, we interviewed three women from our Cambridge BRC. Look out for Rona Smith's full interview on our website in the coming days..
@CUH_NHS @Cambridge_Uni @NIHRresearch @UNESCO @WomenScienceDay

Reply on Twitter 1889373404295279019 Retweet on Twitter 1889373404295279019 Like on Twitter 1889373404295279019 3 Twitter 1889373404295279019
cambridgebrc NIHR Cambridge Biomedical Research Centre @cambridgebrc ·
11 Feb

Happy #InternationalDayofWomenandGirlsinScience
For this global celebration of women in science, we interviewed 3 women from our Cambridge BRC. Look out for Jo McPeake's interview on our website in the coming days
@CUH_NHS @Cambridge_Uni @NIHRresearch @UNESCO @WomenScienceDay

Reply on Twitter 1889372716592963658 Retweet on Twitter 1889372716592963658 Like on Twitter 1889372716592963658 4 Twitter 1889372716592963658
cambridgebrc NIHR Cambridge Biomedical Research Centre @cambridgebrc ·
11 Feb

Happy #InternationalDayofWomenandGirlsinScience
To celebrate this global day, we interviewed three women from our Cambridge BRC. Look out for Deborah's full interview on our website in the coming days..
@CUH_NHS @Cambridge_Uni @NIHRresearch @BEARS_CI @UNESCO @WomenScienceDay

Reply on Twitter 1889370490432639371 Retweet on Twitter 1889370490432639371 2 Like on Twitter 1889370490432639371 4 Twitter 1889370490432639371
cambridgebrc NIHR Cambridge Biomedical Research Centre @cambridgebrc ·
10 Feb

Calling all health researchers based Cambridge/E Anglia: We're so excited to host our all-day in-person #PPI researchers' training at @westcamhub Fri 28 Feb that it's worth echoing what we said earlier: DON'T MISS IT! Email gan23@cam.ac.uk for more info @CUH_NHS @Cambridge_Uni

Reply on Twitter 1888981259780796905 Retweet on Twitter 1888981259780796905 2 Like on Twitter 1888981259780796905 2 Twitter 1888981259780796905
cambridgebrc NIHR Cambridge Biomedical Research Centre @cambridgebrc ·
7 Feb

Researchers from @AngliaRuskin @RoyalPapworth @Cambridge_Uni @UniofHerts @ccs_nhst @CRUK @HLRI_Cambridge @TheCIMR @IMS_MRL @NHSBT @NNUH @MRC_BSU & many more have already signed up for #PPI in-person all-day training 28 Feb @westcamhub. HAVE YOU? Email gan23@cam.ac.uk to book 2/2

Reply on Twitter 1887894339835085107 Retweet on Twitter 1887894339835085107 4 Like on Twitter 1887894339835085107 6 Twitter 1887894339835085107
View more Tweets
© Copyright - NIHR Cambridge Biomedical Research Centre 2025
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.Trial summary and protocol for a phase II randomised placebo-controlled double-blinded...